Magnetic resonance imaging for surrogate outcomes and patient selection.

Suppr

超能文献

作者信息

Hsia Amie W, Kidwell Chelsea S

出版信息

Front Neurol Neurosci. 2009;25:189-192. doi: 10.1159/000209499. Epub 2009 Mar 19.

DOI:10.1159/000209499

PMID:19478521

Abstract

摘要

相似文献

Magnetic resonance imaging for surrogate outcomes and patient selection.

Front Neurol Neurosci. 2009;25:189-192. doi: 10.1159/000209499. Epub 2009 Mar 19.

Structural imaging markers for therapeutic trials in Alzheimer's disease.

J Nutr Health Aging. 2009 Apr;13(4):350-2. doi: 10.1007/s12603-009-0040-y.

Key developments in neurology.

Practitioner. 2003 Jan;247(1642):11-5, 17.

Clinical trials in progressive neurological diseases. Recruitment, enrollment, retention and compliance.

Front Neurol Neurosci. 2009;25:144-151. doi: 10.1159/000209493. Epub 2009 Mar 19.

Magnetic resonance imaging in clinical trials.

Curr Opin Neurol. 2008 Aug;21(4):431-6. doi: 10.1097/WCO.0b013e3283056a3c.

Patient page. Do enough women and minorities take part in drug studies for neurologic diseases?

Neurology. 2011 Jan 25;76(4):e16-7. doi: 10.1212/WNL.0b013e31820a0d90.

Clinical Trials in CNS--SMi Conference.

IDrugs. 2005 Jan;8(1):25-8.

Genetics in clinical trials.

Front Neurol Neurosci. 2009;25:152-157. doi: 10.1159/000209494. Epub 2009 Mar 19.

Manganese neurotoxicity: a review of clinical features, imaging and pathology.

Neurotoxicology. 1999 Apr-Jun;20(2-3):227-38.

Considerations in the design of preclinical safety evaluation programs for novel therapeutics used in neurologic diseases.

Ann N Y Acad Sci. 1995 Sep 15;765:319. doi: 10.1111/j.1749-6632.1995.tb16600.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Magnetic resonance imaging for surrogate outcomes and patient selection.

Front Neurol Neurosci. 2009;25:189-192. doi: 10.1159/000209499. Epub 2009 Mar 19.

Structural imaging markers for therapeutic trials in Alzheimer's disease.

J Nutr Health Aging. 2009 Apr;13(4):350-2. doi: 10.1007/s12603-009-0040-y.

Key developments in neurology.

Practitioner. 2003 Jan;247(1642):11-5, 17.

Clinical trials in progressive neurological diseases. Recruitment, enrollment, retention and compliance.

Front Neurol Neurosci. 2009;25:144-151. doi: 10.1159/000209493. Epub 2009 Mar 19.

Magnetic resonance imaging in clinical trials.

Curr Opin Neurol. 2008 Aug;21(4):431-6. doi: 10.1097/WCO.0b013e3283056a3c.

Patient page. Do enough women and minorities take part in drug studies for neurologic diseases?

Neurology. 2011 Jan 25;76(4):e16-7. doi: 10.1212/WNL.0b013e31820a0d90.

Clinical Trials in CNS--SMi Conference.

IDrugs. 2005 Jan;8(1):25-8.

Genetics in clinical trials.

Front Neurol Neurosci. 2009;25:152-157. doi: 10.1159/000209494. Epub 2009 Mar 19.

Manganese neurotoxicity: a review of clinical features, imaging and pathology.

Neurotoxicology. 1999 Apr-Jun;20(2-3):227-38.

Considerations in the design of preclinical safety evaluation programs for novel therapeutics used in neurologic diseases.

Ann N Y Acad Sci. 1995 Sep 15;765:319. doi: 10.1111/j.1749-6632.1995.tb16600.x.